Lipid-based Phototriggerable Platforms for Improved Delivery of Anticancer Drugs

Anu Puri

Anu Puri

Staff Scientist

Nanobiology Program, Center for Cancer Research, National Cancer Institute at Frederick, NIH

Dr. Puri received her Ph.D. degree in chemistry from the Central Drug Research Institute, Lucknow, India studying the chemical synthesis of modified phospholipids and possible use of their liposomes in drug delivery. Currently she holds the Research Biologist position at the CCR Nanobiology Program, Frederick National Lab for Cancer Research (FNLCR) NCI, NIH. Her research revolves around several themes including (a) Cell Biology of Viral Entry, (b) Development of Lipid-Based Nanoparticles for Targeted Delivery of Cancer Therapeutics (c) Development of nano-scale diagnostic tools for detection of pathogens and cancer biomarkers, and (d) Mechanisms of opportunistic infections in AIDS and related diseases. She has co-authored of over 70 publications, reviews and book chapters. Dr. Puri serves as the reviewer for various grant applications, is involved in several educational activities and has organized and co-chaired meetings and conferences.

Sponsor & Exhibitor Opportunities

Nanotech Conference & Expo  

Microtech Conference & Expo  

Cleantech Conference & Expo  

*Sponsorship Opportunities: Contact Chris Erb

Platinum Sponsor

BASF


Nanotech Platinum Sponsor

Chinano

Association Sponsor

Clean Technology and Sustainable Industries Organization (CTSI)

Producing Sponsors

Nano Science and Technology Institute

TechConnect

TechConnect Acceleration Partners:

BASF
BayerMaterialScience
Battelle
Bosch
bp
Capewell
DOW
GE
Honda
Hyundai
Ingersoll Rand
intel
Lockheed Martin
MWV
Merck
Momentive
National Grid
novaris
Panasonic
PPG
Roche
Sanofi
Shell
siemens
SK Innovation
solvay
Toyota
*Sponsorship Opportunities: Contact Chris Erb

Free Subscription

E-mail:

pbh(); ?>